David Lam is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Lam is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Neuroendocrine Tumor, Small Cell Lung Cancer (SCLC), Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Lam is currently accepting new patients.

Saadia Chohan is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Chohan is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Polycythemia Vera, Familial Colorectal Cancer, Colorectal Cancer, and Paget Disease of the Breast. Dr. Chohan is currently accepting new patients.

Aleda Toma is an Oncologist and a Hematologist in Oklahoma City, Oklahoma. Dr. Toma is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Toma is currently accepting new patients.

Leonard Bowen is a Hematologist Oncology specialist and an Oncologist in Oklahoma City, Oklahoma. Dr. Bowen is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Pleuropulmonary Blastoma, Bone Marrow Aspiration, and Balloon Sinuplasty. Dr. Bowen is currently accepting new patients.

Todd Kliewer is a Hematologist Oncology specialist and an Oncologist in Oklahoma City, Oklahoma. Dr. Kliewer is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Breast Cancer. Dr. Kliewer is currently accepting new patients.

Thy Nguyen is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Nguyen is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Burkitt Lymphoma, Laryngeal Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Nguyen is currently accepting new patients.

Young Chang is a Radiologist and an Interventional Radiologist in Oklahoma City, Oklahoma. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Triple-Negative Breast Cancer, Breast Cancer, Pleurisy, Bone Marrow Aspiration, and Liver Embolization. Dr. Chang is currently accepting new patients.

Adam Asch is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Asch is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Asch is currently accepting new patients.

Taha Al is a Hematologist and an Oncologist in Oklahoma City, Oklahoma. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Colonoscopy.

Mohamad Khawandanah is a Hematologist and an Oncologist in Oklahoma City, Oklahoma. Dr. Khawandanah is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Myeloid Leukemia (AML), Hodgkin Lymphoma, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Khawandanah is currently accepting new patients.

Julie Chan is a Nurse Practitioner in Oklahoma City, Oklahoma. Ms. Chan is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Small Lymphocytic Lymphoma (SLL). Ms. Chan is currently accepting new patients.

Jennifer Holter-Chakrabarty is a Hematologist Oncology specialist and an Emergency Medicine provider in Oklahoma City, Oklahoma. Dr. Holter-Chakrabarty is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Sickle Cell Disease, Multiple Myeloma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Holter-Chakrabarty is currently accepting new patients.

George Selby is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Selby is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Selby is currently accepting new patients.

Jehanzeb Riaz is a Hematologist Oncology specialist and an Oncologist in Oklahoma City, Oklahoma. Dr. Riaz is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Pleuropulmonary Blastoma, Paget Disease of the Breast, Breast Cancer, Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Riaz is currently accepting new patients.

Laura Brett is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Brett is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma. Dr. Brett is currently accepting new patients.

Patricia Whitt is a Physician Assistant in Oklahoma City, Oklahoma. Ms. Whitt is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Classical Hodgkin Lymphoma, Smoldering Multiple Myeloma, and Small Lymphocytic Lymphoma (SLL).

Michael Confer is a Radiation Oncologist in Oklahoma City, Oklahoma. Dr. Confer is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Melanoma of the Eye, Familial Prostate Cancer, Squamous Cell Skin Carcinoma, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Confer is currently accepting new patients.

Jess Armor is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Armor is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Small Lymphocytic Lymphoma (SLL), Large-Cell Immunoblastic Lymphoma, Multiple Myeloma, Primary Lymphoma of the Brain, and Bone Marrow Aspiration. Dr. Armor is currently accepting new patients.

Robert Reynolds is a Hematologist Oncology specialist and an Oncologist in Oklahoma City, Oklahoma. Dr. Reynolds is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Familial Colorectal Cancer, Lung Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Bone Marrow Aspiration. Dr. Reynolds is currently accepting new patients.

Sanjaykumar Hapani is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Hapani is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Familial Colorectal Cancer, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration. Dr. Hapani is currently accepting new patients.